Complete Atrioventricular Block Secondary to Bortezomib Use in Multiple Myeloma
Yonsei Medical Journal
;
: 196-198, 2011.
Article
in English
| WPRIM
| ID: wpr-136362
ABSTRACT
Bortezomib is an inhibitor of 26S proteasome, which is an effective treatment for multiple myeloma. The common adverse effects of bortezomib are asthenic conditions, gastrointestinal disturbances, and peripheral neuropathy. Here we describe a patient with dyspnea and general weakness because of complete atrioventricular block while receiving bortezomib. We immediately stopped bortezomib, and after inserting a permanent VDD pacemaker, the patients' symptoms disappeared.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pyrazines
/
Boronic Acids
/
Atrioventricular Block
/
Multiple Myeloma
Limits:
Female
/
Humans
Language:
English
Journal:
Yonsei Medical Journal
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS